nach oben

Erschienen in:

09.11.2023 | Review

Postoperative Scar Management Protocol for Asian Patients

verfasst von: Hargaven Singh Gill, Low O-Wern, Priya Tiwari, Gurveer Kaven Singh Gill, Chance Goh, Janet Hung, Jing Tzer Lee, Thiam Chye Lim, Jane Lim, Yan Lin Yap, Vigneswaran Nallathamby

Erschienen in: Aesthetic Plastic Surgery | Ausgabe 3/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

Postoperative scar formation remains a morbidity for patients even with the advent of minimally invasive techniques. Furthermore, the significant difference between the Asian and Caucasian skin results in poorer postoperative scar outcomes in Asians, supporting the need for an evidence-based scar management protocol.

Methods

Following a literature review of the PubMed and the Cochrane databases over the past 10 years, we constructed a novel postoperative scar management protocol for the Asian skin, utilized in a Singaporean tertiary healthcare institution.

Results

We describe a timeline-based scar protocol from the point of skin closure to a minimum of 1 year of follow-up. We support the use of intraoperative botulinum toxin for selected high-risk individuals upon skin closure with a follow-up regimen in the postoperative setting. For recalcitrant keloids, we have described a multimodal therapy comprising elements of intralesional steroids, botulinum toxin, lasers, surgery, and radiotherapy.

Conclusions

A consolidated postoperative scar management protocol provides the necessary guidance for improved scar outcomes in the Asian skin. There is inherent potential in expanding the protocol to include post-traumatic and burn wounds or support other skin types including the Caucasian skin.

No Level Assigned

This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.

Soltani AM, Francis CS, Motamed A, Karatsonyi AL, Hammoudeh JA, Sanchez-Lara PA et al (2012) Hypertrophic scarring in cleft lip repair: a comparison of incidence among ethnic groups. Clin Epidemiol 4:187–191PubMedPubMedCentral

Ogawa R, Dohi T, Tosa M, Aoki M, Akaishi S (2021) The latest strategy for keloid and hypertrophic scar prevention and treatment: the nippon medical school (NMS) protocol. J Nippon Med Sch 88(1):2–9PubMedCrossRef

Lv K, Xia Z (2018) Chinese expert consensus on clinical prevention and treatment of scar. Burns Trauma 6:27PubMedPubMedCentralCrossRef

Potter DA, Veitch D, Johnston GA (2019) Scarring and wound healing. Br J Hosp Med Lond 80(11):C166–C171PubMedCrossRef

Dohi T, Padmanabhan J, Akaishi S, Than PA, Terashima M, Matsumoto NN et al (2019) The interplay of mechanical stress, strain, and stiffness at the keloid periphery correlates with increased caveolin-1/ROCK signaling and scar progression. Plast Reconstr Surg 144(1):58e–67ePubMedCrossRef

Quong WL, Kozai Y, Ogawa R (2017) A case of keloids complicated by castleman’s disease: interleukin-6 as a keloid risk factor. Plast Reconstr Surg Glob Open 5(5):e1336PubMedPubMedCentralCrossRef

van der Veer WM, Bloemen MC, Ulrich MM, Molema G, van Zuijlen PP, Middelkoop E et al (2009) Potential cellular and molecular causes of hypertrophic scar formation. Burns 35(1):15–29PubMedCrossRef

Ogawa R (2017) Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis. Int J Mol Sci 18(3):526489ADSCrossRef

Ogawa R, Okai K, Tokumura F, Mori K, Ohmori Y, Huang C et al (2012) The relationship between skin stretching/contraction and pathologic scarring: the important role of mechanical forces in keloid generation. Wound Repair Regen 20(2):149–157PubMedCrossRef

10.

Harn HI, Ogawa R, Hsu CK, Hughes MW, Tang MJ, Chuong CM (2019) The tension biology of wound healing. Exp Dermatol 28(4):464–471PubMedCrossRef

11.

Park TH, Chang CH (2012) Keloid recurrence in pregnancy. Aesthet Plast Surg 36(5):1271–1272CrossRef

12.

Kim HD, Hwang SM, Lim KR, Jung YH, Ahn SM, Kim SJ (2013) Recurrent auricular keloids during pregnancy. Arch Plast Surg 40(1):70–72PubMedPubMedCentralCrossRef

13.

Arima J, Huang C, Rosner B, Akaishi S, Ogawa R (2015) Hypertension: a systemic key to understanding local keloid severity. Wound Repair Regen. 23(2):213–221PubMedCrossRef

14.

Dong X, Mao S, Wen H (2013) Upregulation of proinflammatory genes in skin lesions may be the cause of keloid formation (Review). Biomed Rep 1(6):833–836PubMedPubMedCentralCrossRef

15.

Marneros AG, Norris JE, Olsen BR, Reichenberger E (2001) Clinical genetics of familial keloids. Arch Dermatol 137(11):1429–1434PubMedCrossRef

16.

Nakashima M, Chung S, Takahashi A, Kamatani N, Kawaguchi T, Tsunoda T et al (2010) A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population. Nat Genet 42(9):768–771PubMedCrossRef

17.

Ogawa R, Watanabe A, Than Naing B, Sasaki M, Fujita A, Akaishi S et al (2014) Associations between keloid severity and single-nucleotide polymorphisms: importance of rs8032158 as a biomarker of keloid severity. J Invest Dermatol 134(7):2041–2043PubMedCrossRef

18.

Fujita M, Yamamoto Y, Jiang JJ, Atsumi T, Tanaka Y, Ohki T et al (2019) NEDD4 Is involved in inflammation development during keloid formation. J Invest Dermatol 139(2):333–341PubMedCrossRef

19.

Abdu Allah AMK, Mohammed KI, Farag AGA, Hagag MM, Essam M, Tayel NR (2019) Interleukin-6 serum level and gene polymorphism in keloid patients. Cell Mol Biol Noisy Grand 65(5):43–48CrossRef

20.

Chen Y, Gao JH, Liu XJ, Yan X, Song M (2006) Characteristics of occurrence for Han Chinese familial keloids. Burns 32(8):1052–1059PubMedCrossRef

21.

Hosalkar H, Greenberg J, Gaugler RL, Garg S, Dormans JP (2007) Abnormal scarring with keloid formation after osteochondroma excision in children with multiple hereditary exostoses. J Pediatr Orthop 27(3):333–337PubMedCrossRef

22.

Miller MC, Nanchahal J (2005) Advances in the modulation of cutaneous wound healing and scarring. Bio Drugs 19(6):363–381

23.

Ogawa R, Miyashita T, Hyakusoku H, Akaishi S, Kuribayashi S, Tateno A (2007) Postoperative radiation protocol for keloids and hypertrophic scars: statistical analysis of 370 sites followed for over 18 months. Ann Plast Surg 59(6):688–691PubMedCrossRef

24.

Reiffel RS (1995) Prevention of hypertrophic scars by long-term paper tape application. Plast Reconstr Surg 96(7):1715–1718PubMedCrossRef

25.

Son D, Harijan A (2014) Overview of surgical scar prevention and management. J Korean Med Sci 29(6):751–757PubMedPubMedCentralCrossRef

26.

Lubczynska A, Garncarczyk A, Wcislo-Dziadecka D (2023) Effectiveness of various methods of manual scar therapy. Skin Res Technol 29(3):e13272PubMedPubMedCentralCrossRef

27.

Singapore Government (2022) Health sciences authority Singapore [cited 2022 24th August 2022]. Available from: https://www.hsa.gov.sg/

28.

Monstrey S, Middelkoop E, Vranckx JJ, Bassetto F, Ziegler UE, Meaume S et al (2014) Updated scar management practical guidelines: non-invasive and invasive measures. J Plast Reconstr Aesthet Surg 67(8):1017–1025PubMedCrossRef

29.

Kim S, Choi TH, Liu W, Ogawa R, Suh JS, Mustoe TA (2013) Update on scar management: guidelines for treating Asian patients. Plast Reconstr Surg 132(6):1580–1589PubMedCrossRef

30.

O’Brien L, Jones DJ (2013) Silicone gel sheeting for preventing and treating hypertrophic and keloid scars. Cochr Database Syst Rev 2013(9):003826

31.

Hsu KC, Luan CW, Tsai YW (2017) Review of silicone gel sheeting and silicone gel for the prevention of hypertrophic scars and keloids. Wounds 29(5):154–158PubMed

32.

Chan KY, Lau CL, Adeeb SM, Somasundaram S, Nasir-Zahari M (2005) A randomized, placebo-controlled, double-blind, prospective clinical trial of silicone gel in prevention of hypertrophic scar development in median sternotomy wound. Plast Reconstr Surg 116(4):1013–20PubMedCrossRef

33.

Sharma M, Wakure A (2013) Scar revision. Indian J Plast Surg. 46(2):408–418PubMedPubMedCentralCrossRef

34.

Jourdan M, Madfes DC, Lima E, Tian Y, Seite S (2019) Skin care management for medical and aesthetic procedures to prevent scarring. Clin Cosmet Investig Dermatol 12:799–804PubMedPubMedCentralCrossRef

35.

Commander SJ, Chamata E, Cox J, Dickey RM, Lee EI (2016) Update on postsurgical scar management. Semin Plast Surg 30(3):122–128PubMedPubMedCentralCrossRef

36.

Cho JW, Cho SY, Lee SR, Lee KS (2010) Onion extract and quercetin induce matrix metalloproteinase-1 in vitro and in vivo. Int J Mol Med 25(3):347–352MathSciNetPubMed

37.

Jenwitheesuk K, Surakunprapha P, Jenwitheesuk K, Kuptarnond C, Prathanee S, Intanoo W (2012) Role of silicone derivative plus onion extract gel in presternal hypertrophic scar protection: a prospective randomized, double blinded, controlled trial. Int Wound J 9(4):397–402PubMedCrossRef

38.

Khansa I, Harrison B, Janis JE (2016) Evidence-based scar management: how to improve results with technique and technology. Plast Reconstr Surg 138(3 Suppl):165S-S178PubMedCrossRef

39.

Hosnuter M, Payasli C, Isikdemir A, Tekerekoglu B (2007) The effects of onion extract on hypertrophic and keloid scars. J Wound Care 16(6):251–254PubMedCrossRef

40.

Chung VQ, Kelley L, Marra D, Jiang SB (2006) Onion extract gel versus petrolatum emollient on new surgical scars: prospective double-blinded study. Dermatol Surg 32(2):193–197PubMed

41.

Gold MH, Berman B, Clementoni MT, Gauglitz GG, Nahai F, Murcia C (2014) Updated international clinical recommendations on scar management: part 1–evaluating the evidence. Dermatol Surg 40(8):817–824PubMed

42.

Shin TM, Bordeaux JS (2012) The role of massage in scar management: a literature review. Dermatol Surg 38(3):414–423PubMedCrossRef

43.

Aarabi S, Bhatt KA, Shi Y, Paterno J, Chang EI, Loh SA et al (2007) Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis. Faseb J 21(12):3250–3261PubMedCrossRef

44.

Berman B, Viera MH, Amini S, Huo R, Jones IS (2008) Prevention and management of hypertrophic scars and keloids after burns in children. J Craniofac Surg 19(4):989–1006PubMedCrossRef

45.

Ai JW, Liu JT, Pei SD, Liu Y, Li DS, Lin HM et al (2017) The effectiveness of pressure therapy (15–25 mmHg) for hypertrophic burn scars: a systematic review and meta-analysis. Sci Rep 7:40185ADSPubMedPubMedCentralCrossRef

46.

Macintyre L, Baird M (2006) Pressure garments for use in the treatment of hypertrophic scars—a review of the problems associated with their use. Burns 32(1):10–15PubMedCrossRef

47.

Ketchum LD, Smith J, Robinson DW, Masters FW (1966) The treatment of hypertrophic scar, keloid and scar contracture by triamcinolone acetonide. Plast Reconstr Surg 38(3):209–218PubMedCrossRef

48.

Morelli Coppola M, Salzillo R, Segreto F, Persichetti P (2018) Triamcinolone acetonide intralesional injection for the treatment of keloid scars: patient selection and perspectives. Clin Cosmet Investig Dermatol 11:387–396PubMedPubMedCentralCrossRef

49.

Roques C, Teot L (2008) The use of corticosteroids to treat keloids: a review. Int J Low Extrem Wounds 7(3):137–145PubMedCrossRef

50.

Tan CWX, Tan WD, Srivastava R, Yow AP, Wong DWK, Tey HL (2019) Dissolving triamcinolone-embedded microneedles for the treatment of keloids: a single-blinded intra-individual controlled clinical trial. Dermatol Ther Heidelb 9(3):601–611PubMedPubMedCentralCrossRef

51.

Kasyanju Carrero LM, Ma WW, Liu HF, Yin XF, Zhou BR (2019) Botulinum toxin type A for the treatment and prevention of hypertrophic scars and keloids: Updated review. J Cosmet Dermatol 18(1):10–15PubMedCrossRef

52.

Li YH, Yang J, Liu JQ, Xie ST, Zhang YJ, Zhang W et al (2018) A randomized, placebo-controlled, double-blind, prospective clinical trial of botulinum toxin type A in prevention of hypertrophic scar development in median sternotomy wound. Aesthetic Plast Surg 42(5):1364–1369PubMedCrossRef

53.

Huang RL, Ho CK, Tremp M, Xie Y, Li Q, Zan T (2019) Early postoperative application of botulinum toxin type A prevents hypertrophic scarring after epicanthoplasty: a split-face, double-blind. Randomized Trial Plast Reconstr Surg 144(4):835–844PubMedCrossRef

54.

Bi M, Sun P, Li D, Dong Z, Chen Z (2019) Intralesional injection of botulinum toxin type A compared with intralesional injection of corticosteroid for the treatment of hypertrophic scar and keloid: a systematic review and meta-analysis. Med Sci Monit 25:2950–2958PubMedPubMedCentralCrossRef

55.

Wu WTL (2011) Skin resurfacing with Microbotox and the treatment of keloids. In: Benedetto AV (ed) Botulinum toxins in clinical aesthetic practice, 2nd edn. Informa Health Care, pp 190–205

56.

Khoury JG, Saluja R, Goldman MP (2008) The effect of botulinum toxin type A on full-face intense pulsed light treatment: a randomized, double-blind, split-face study. Dermatol Surg 34(8):1062–1069PubMed

57.

Gamil HD, Khattab FM, El Fawal MM, Eldeeb SE (2020) Comparison of intralesional triamcinolone acetonide, botulinum toxin type A, and their combination for the treatment of keloid lesions. J Dermatol Treat 31(5):535–544CrossRef

58.

Bouzari N, Davis SC, Nouri K (2007) Laser treatment of keloids and hypertrophic scars. Int J Dermatol 46(1):80–88PubMedCrossRef

59.

Al-Mohamady Ael S, Ibrahim SM, Muhammad MM (2016) Pulsed dye laser versus long-pulsed Nd:YAG laser in the treatment of hypertrophic scars and keloid: a comparative randomized split-scar trial. J Cosmet Laser Ther 18(4):208–212CrossRef

60.

Kono T, Ercocen AR, Nakazawa H, Honda T, Hayashi N, Nozaki M (2003) The flashlamp-pumped pulsed dye laser (585 nm) treatment of hypertrophic scars in Asians. Ann Plast Surg 51(4):366–371PubMedCrossRef

61.

Jin R, Huang X, Li H, Yuan Y, Li B, Cheng C et al (2013) Laser therapy for prevention and treatment of pathologic excessive scars. Plast Reconstr Surg 132(6):1747–1758PubMedCrossRef

62.

Koike S, Akaishi S, Nagashima Y, Dohi T, Hyakusoku H, Ogawa R (2014) Nd:YAG laser treatment for keloids and hypertrophic scars: an analysis of 102 cases. Plast Reconstr Surg Glob Open 2(12):e272PubMedCrossRef

63.

Tsai CH, Kao HK, Akaishi S, An-Jou Lin J, Ogawa R (2020) Combination of 1,064-nm neodymium-doped yttrium aluminum garnet laser and steroid tape decreases the total treatment time of hypertrophic scars: an analysis of 40 cases of cesarean-section scars. Dermatol Surg 46(8):1062–1067PubMedCrossRef

64.

Khatri KA, Mahoney DL, McCartney MJ (2011) Laser scar revision: a review. J Cosmet Laser Ther 13(2):54–62PubMedCrossRef

65.

Seegenschmiedt MH, Micke O, Niewald M, Mucke R, Eich HT, Kriz J et al (2015) Degro guidelines for the radiotherapy of non-malignant disorders: part III: hyperproliferative disorders. Strahlenther Onkol 191(7):541–548PubMedCrossRef

66.

Ogawa R, Tosa M, Dohi T, Akaishi S, Kuribayashi S (2019) Surgical excision and postoperative radiotherapy for keloids. Scars Burn Heal. 5:2059513119891113PubMedPubMedCentral

67.

Ogawa R (2022) The most current algorithms for the treatment and prevention of hypertrophic scars and keloids: a 2020 update of the algorithms published 10 years ago. Plast Reconstr Surg 149(1):79e–94ePubMedCrossRef

68.

Arima J, Dohi T, Kuribayashi S, Akaishi S, Ogawa R (2019) Z-plasty and postoperative radiotherapy for anterior chest wall keloids: an analysis of 141 patients. Plast Reconstr Surg Glob Open 7(3):e2177PubMedPubMedCentralCrossRef

69.

Dohi T, Kuribayashi S, Tosa M, Aoki M, Akaishi S, Ogawa R (2019) Z-plasty and postoperative radiotherapy for upper-arm keloids: an analysis of 38 patients. Plast Reconstr Surg Glob Open 7(11):e2496PubMedPubMedCentralCrossRef

70.

Al Aradi IK, Alawadhi SA, Alkhawaja FA, Alaradi I (2013) Earlobe keloids: a pilot study of the efficacy of keloidectomy with core fillet flap and adjuvant intralesional corticosteroids. Dermatol Surg 39(10):1514–1519PubMedCrossRef

71.

Akita S, Akino K, Yakabe A, Imaizumi T, Tanaka K, Anraku K et al (2007) Combined surgical excision and radiation therapy for keloid treatment. J Craniofac Surg 18(5):1164–1169PubMedCrossRef

72.

Singapore Department of Statistics (2020) Census of population 2020 statistical release 1. Available from: https://www.singstat.gov.sg/-/media/files/publications/cop2020/sr1/findings.pdf

73.

Alhady SM, Sivanantharajah K (1969) Keloids in various races. A review of 175 cases. Plast Reconstr Surg 44(6):564–6PubMedCrossRef

Titel: Postoperative Scar Management Protocol for Asian Patients
verfasst von: Hargaven Singh Gill
Low O-Wern
Priya Tiwari
Gurveer Kaven Singh Gill
Chance Goh
Janet Hung
Jing Tzer Lee
Thiam Chye Lim
Jane Lim
Yan Lin Yap
Vigneswaran Nallathamby
Publikationsdatum: 09.11.2023
Verlag: Springer US
Erschienen in: Aesthetic Plastic Surgery / Ausgabe 3/2024
Print ISSN: 0364-216X
Elektronische ISSN: 1432-5241
DOI: https://doi.org/10.1007/s00266-023-03696-2

Neu im Fachgebiet Chirurgie

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Postoperative Scar Management Protocol for Asian Patients